Comparison Overview

SUN PHARMA

VS

Lupin

SUN PHARMA

Sun House, CTS No. 201 B/1,, Mumbai, 400063, IN
Last Update: 2026-04-01
Between 800 and 849

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 44,544
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0

Lupin

3rd Floor, Kalpataru Inspire, Off Western Express Highway, Santa Cruz East, Mumbai, Maharashtra, IN, 400055
Last Update: 2026-04-02
Between 750 and 799

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 21,369
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/sun-pharma.jpeg
SUN PHARMA
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/lupin.jpeg
Lupin
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
SUN PHARMA
100%
Compliance Rate
0/4 Standards Verified
Lupin
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for SUN PHARMA in 2026.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Lupin in 2026.

Incident History — SUN PHARMA (X = Date, Y = Severity)

SUN PHARMA cyber incidents detection timeline including parent company and subsidiaries

Incident History — Lupin (X = Date, Y = Severity)

Lupin cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/sun-pharma.jpeg
SUN PHARMA
Incidents

No Incident

https://images.rankiteo.com/companyimages/lupin.jpeg
Lupin
Incidents

No Incident

FAQ

SUN PHARMA company demonstrates a stronger AI Cybersecurity Score compared to Lupin company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Lupin company has disclosed a higher number of cyber incidents compared to SUN PHARMA company.

In the current year, Lupin company and SUN PHARMA company have not reported any cyber incidents.

Neither Lupin company nor SUN PHARMA company has reported experiencing a ransomware attack publicly.

Neither Lupin company nor SUN PHARMA company has reported experiencing a data breach publicly.

Neither Lupin company nor SUN PHARMA company has reported experiencing targeted cyberattacks publicly.

Neither SUN PHARMA company nor Lupin company has reported experiencing or disclosing vulnerabilities publicly.

Neither SUN PHARMA nor Lupin holds any compliance certifications.

Neither company holds any compliance certifications.

SUN PHARMA company has more subsidiaries worldwide compared to Lupin company.

SUN PHARMA company employs more people globally than Lupin company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither SUN PHARMA nor Lupin holds SOC 2 Type 1 certification.

Neither SUN PHARMA nor Lupin holds SOC 2 Type 2 certification.

Neither SUN PHARMA nor Lupin holds ISO 27001 certification.

Neither SUN PHARMA nor Lupin holds PCI DSS certification.

Neither SUN PHARMA nor Lupin holds HIPAA certification.

Neither SUN PHARMA nor Lupin holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

nimiq/core-rs-albatross is a Rust implementation of the Nimiq Proof-of-Stake protocol based on the Albatross consensus algorithm. Prior to version 1.3.0, two peer-facing consensus request handlers assume that the history index is always available and call blockchain.history_store.history_index().unwrap() directly. That assumption is false by construction. HistoryStoreProxy::history_index() explicitly returns None for the valid HistoryStoreProxy::WithoutIndex state. when a full node is syncing or otherwise running without the history index, a remote peer can send RequestTransactionsProof or RequestTransactionReceiptsByAddress and trigger an Option::unwrap() panic on the request path. This issue has been patched in version 1.3.0.

Risk Information
cvss3
Base: 5.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L
Description

PraisonAI is a multi-agent teams system. Prior to version 1.5.95, FileTools.download_file() in praisonaiagents validates the destination path but performs no validation on the url parameter, passing it directly to httpx.stream() with follow_redirects=True. An attacker who controls the URL can reach any host accessible from the server including cloud metadata services and internal network services. This issue has been patched in version 1.5.95.

Risk Information
cvss3
Base: 8.6
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
Description

PraisonAI is a multi-agent teams system. Prior to version 4.5.97, OAuthManager.validate_token() returns True for any token not found in its internal store, which is empty by default. Any HTTP request to the MCP server with an arbitrary Bearer token is treated as authenticated, granting full access to all registered tools and agent capabilities. This issue has been patched in version 4.5.97.

Risk Information
cvss3
Base: 9.1
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
Description

PraisonAI is a multi-agent teams system. Prior to version 4.5.97, the PraisonAI Gateway server accepts WebSocket connections at /ws and serves agent topology at /info with no authentication. Any network client can connect, enumerate registered agents, and send arbitrary messages to agents and their tool sets. This issue has been patched in version 4.5.97.

Risk Information
cvss3
Base: 9.1
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
Description

PraisonAI is a multi-agent teams system. Prior to version 4.5.90, MCPToolIndex.search_tools() compiles a caller-supplied string directly as a Python regular expression with no validation, sanitization, or timeout. A crafted regex causes catastrophic backtracking in the re engine, blocking the Python thread for hundreds of seconds and causing a complete service outage. This issue has been patched in version 4.5.90.

Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H